Powl Brian T. (CIK 1934232) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-24). Recent activity: Sell KURA (4,345 shares), Sell KURA (10,000 shares), Sell KURA (339 shares), Sell KURA (4,842 shares), Sell KURA (1,572 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-24 | Kura Oncology, Inc. (KURA) | Chief Commercial Officer | Sell | 4,345 | $51,663 |
| 2026-05-22 | Kura Oncology, Inc. (KURA) | Chief Commercial Officer | Sell | 10,000 | $110,000 |
| 2026-05-20 | Kura Oncology, Inc. (KURA) | Chief Commercial Officer | Sell | 339 | $3,122 |
| 2026-01-27 | Kura Oncology, Inc. (KURA) | Chief Commercial Officer | Sell | 4,842 | $40,963 |
| 2026-01-27 | Kura Oncology, Inc. (KURA) | Chief Commercial Officer | Sell | 1,572 | $13,299 |
| 2026-01-06 | Kura Oncology, Inc. (KURA) | Chief Commercial Officer | Buy | 50,000 | $0 |
| 2025-11-14 | Kura Oncology, Inc. (KURA) | Chief Commercial Officer | Buy | 48,900 | $0 |
| 2025-11-14 | Kura Oncology, Inc. (KURA) | Chief Commercial Officer | Sell | 8,887 | $99,357 |
| 2025-09-29 | Kura Oncology, Inc. (KURA) | Chief Commercial Officer | Buy | 48,900 | $0 |
| 2025-09-29 | Kura Oncology, Inc. (KURA) | Chief Commercial Officer | Sell | 8,891 | $79,486 |
来源：SEC Form 4 申报文件 · 截至 2026-08-24